Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Apr 1;101(7):1500–1508. doi: 10.1172/JCI1758

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

D M Koelle 1, C M Posavad 1, G R Barnum 1, M L Johnson 1, J M Frank 1, L Corey 1
PMCID: PMC508728  PMID: 9525993

Abstract

The mechanisms involved in host clearance of symptomatic mucocutaneous herpes simplex virus (HSV) infection are unclear. We studied the functional properties of bulk cultures of skin-infiltrating lymphocytes from normal skin and serial biopsies of recurrent genital HSV-2 lesions, and compared HSV-specific and NK responses with viral clearance. HSV-specific CD4+ or CD8+ T cells were rarely detected in lymphocytes cultured from normal skin. The total lymphocyte count and HSV-specific and NK-like effector cell activities were markedly higher in cultures derived from lesional skin. HSV-specific CD4+ proliferative responses and NK-like cytotoxic responses were present at all stages of herpetic lesions, including biopsies early in the disease course. In contrast, cytotoxic T lymphocyte activity was generally low among cells derived from early culture-positive lesions, and increased during lesion evolution. Viral clearance from the lesion site was associated with a high level of local cytolytic activity towards HSV-infected cells. The phenotypes of cells with HSV-specific cytotoxic responses varied between patients, having CD4+ and CD8+ components. Immunotherapeutic approaches to HSV should be directed at improving in vivo cytolytic activity to HSV.

Full Text

The Full Text of this article is available as a PDF (265.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley R. L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. doi: 10.1128/jcm.26.4.662-667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashley R., Benedetti J., Corey L. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol. 1985 Oct;17(2):153–166. doi: 10.1002/jmv.1890170208. [DOI] [PubMed] [Google Scholar]
  3. Bukowski J. F., Morita C. T., Brenner M. B. Recognition and destruction of virus-infected cells by human gamma delta CTL. J Immunol. 1994 Dec 1;153(11):5133–5140. [PubMed] [Google Scholar]
  4. Burke R. L. Contemporary approaches to vaccination against herpes simplex virus. Curr Top Microbiol Immunol. 1992;179:137–158. doi: 10.1007/978-3-642-77247-4_9. [DOI] [PubMed] [Google Scholar]
  5. Corey L., Adams H. G., Brown Z. A., Holmes K. K. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983 Jun;98(6):958–972. doi: 10.7326/0003-4819-98-6-958. [DOI] [PubMed] [Google Scholar]
  6. Cunningham A. L., Nelson P. A., Fathman C. G., Merigan T. C. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. J Gen Virol. 1985 Feb;66(Pt 2):249–258. doi: 10.1099/0022-1317-66-2-249. [DOI] [PubMed] [Google Scholar]
  7. Cunningham A. L., Turner R. R., Miller A. C., Para M. F., Merigan T. C. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest. 1985 Jan;75(1):226–233. doi: 10.1172/JCI111678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doymaz M. Z., Rouse B. T. Immunopathology of herpes simplex virus infections. Curr Top Microbiol Immunol. 1992;179:121–136. doi: 10.1007/978-3-642-77247-4_8. [DOI] [PubMed] [Google Scholar]
  9. Fitzgerald-Bocarsly P., Howell D. M., Pettera L., Tehrani S., Lopez C. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J Virol. 1991 Jun;65(6):3151–3160. doi: 10.1128/jvi.65.6.3151-3160.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jerome K. R., Tait J. F., Koelle D. M., Corey L. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol. 1998 Jan;72(1):436–441. doi: 10.1128/jvi.72.1.436-441.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Koelle D. M., Abbo H., Peck A., Ziegweid K., Corey L. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis. 1994 May;169(5):956–961. doi: 10.1093/infdis/169.5.956. [DOI] [PubMed] [Google Scholar]
  12. Koelle D. M., Corey L., Burke R. L., Eisenberg R. J., Cohen G. H., Pichyangkura R., Triezenberg S. J. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol. 1994 May;68(5):2803–2810. doi: 10.1128/jvi.68.5.2803-2810.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koelle D. M., Johnson M. L., Ekstrom A. N., Byers P., Kwok W. W. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. Hum Immunol. 1997 Apr 1;53(2):195–205. doi: 10.1016/S0198-8859(97)00034-7. [DOI] [PubMed] [Google Scholar]
  14. Koelle D. M., Tigges M. A., Burke R. L., Symington F. W., Riddell S. R., Abbo H., Corey L. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J Clin Invest. 1993 Mar;91(3):961–968. doi: 10.1172/JCI116317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koutsky L. A., Stevens C. E., Holmes K. K., Ashley R. L., Kiviat N. B., Critchlow C. W., Corey L. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992 Jun 4;326(23):1533–1539. doi: 10.1056/NEJM199206043262305. [DOI] [PubMed] [Google Scholar]
  16. Koyama A. H., Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J Virol. 1997 Mar;71(3):2567–2571. doi: 10.1128/jvi.71.3.2567-2571.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kwok W. W., Domeier M. E., Johnson M. L., Nepom G. T., Koelle D. M. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med. 1996 Mar 1;183(3):1253–1258. doi: 10.1084/jem.183.3.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laird N. M., Ware J. H. Random-effects models for longitudinal data. Biometrics. 1982 Dec;38(4):963–974. [PubMed] [Google Scholar]
  19. Lanier L. L., Le A. M., Civin C. I., Loken M. R., Phillips J. H. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986 Jun 15;136(12):4480–4486. [PubMed] [Google Scholar]
  20. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  21. Perussia B., Starr S., Abraham S., Fanning V., Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol. 1983 May;130(5):2133–2141. [PubMed] [Google Scholar]
  22. Posavad C. M., Koelle D. M., Corey L. High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J Virol. 1996 Nov;70(11):8165–8168. doi: 10.1128/jvi.70.11.8165-8168.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reinherz E. L., Morimoto C., Fitzgerald K. A., Hussey R. E., Daley J. F., Schlossman S. F. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol. 1982 Jan;128(1):463–468. [PubMed] [Google Scholar]
  24. Schiavon V., Roth P., Bolton W. E., Farcet J. P., Bensussan A., Boumsell L. Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. Tissue Antigens. 1996 Oct;48(4 Pt 1):312–318. doi: 10.1111/j.1399-0039.1996.tb02650.x. [DOI] [PubMed] [Google Scholar]
  25. Schmid D. S., Rouse B. T. The role of T cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol. 1992;179:57–74. doi: 10.1007/978-3-642-77247-4_4. [DOI] [PubMed] [Google Scholar]
  26. Tigges M. A., Koelle D., Hartog K., Sekulovich R. E., Corey L., Burke R. L. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J Virol. 1992 Mar;66(3):1622–1634. doi: 10.1128/jvi.66.3.1622-1634.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tigges M. A., Leng S., Johnson D. C., Burke R. L. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol. 1996 May 15;156(10):3901–3910. [PubMed] [Google Scholar]
  28. Topalian S. L., Muul L. M., Solomon D., Rosenberg S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods. 1987 Aug 24;102(1):127–141. doi: 10.1016/s0022-1759(87)80018-2. [DOI] [PubMed] [Google Scholar]
  29. Van Voorhis W. C., Barrett L. K., Koelle D. M., Nasio J. M., Plummer F. A., Lukehart S. A. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J Infect Dis. 1996 Feb;173(2):491–495. doi: 10.1093/infdis/173.2.491. [DOI] [PubMed] [Google Scholar]
  30. Yasukawa M., Inatsuki A., Kobayashi Y. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells. J Immunol. 1989 Sep 15;143(6):2051–2057. [PubMed] [Google Scholar]
  31. Yasukawa M., Inatsuki A., Kobayashi Y. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. J Immunol. 1988 May 15;140(10):3419–3425. [PubMed] [Google Scholar]
  32. Yasukawa M., Kobayashi Y. Inhibition of herpes simplex virus replication in vitro by human cytotoxic T cell clones and natural killer cell clones. J Gen Virol. 1985 Oct;66(Pt 10):2225–2229. doi: 10.1099/0022-1317-66-10-2225. [DOI] [PubMed] [Google Scholar]
  33. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol. 1984 Jul;133(1):422–427. [PubMed] [Google Scholar]
  34. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. J Immunol. 1984 Nov;133(5):2736–2742. [PubMed] [Google Scholar]
  35. Zarling J. M., Moran P. A., Burke R. L., Pachl C., Berman P. W., Lasky L. A. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. J Immunol. 1986 Jun 15;136(12):4669–4673. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES